Novel matrix metalloproteinase inhibitors: Generation of lead compounds by the in silico fragment-based approach-Reference-Cited by-同舟云学术

Novel matrix metalloproteinase inhibitors: Generation of lead compounds by the in silico fragment-based approach

Published:2005-07 Issue:14 Volume:13 Page:4527-4543
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Takahashi Kanji,Ikura Masahiro,Habashita Hiromu,Nishizaki Minoru,Sugiura Tsuneyuki,Yamamoto Shingo,Nakatani Shingo,Ogawa Koji,Ohno Hiroyuki,Nakai Hisao,Toda Masaaki

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference8 articles.

1. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development;Supuran,2002

2. Matrix Metalloproteinases and TIMPs;Woessner,2000

3. 1.56 Å structure of mature truncated human fibroblast collagenase

4. Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transition-Metal-Free N-Arylation of N-Methoxysulfonamides and N,O-Protected Hydroxylamines with Trimethoxyphenyliodonium (III) Acetates;Synthesis;2022-08-11

2. Diaryl Ether: A Privileged Scaffold for Drug and Agrochemical Discovery;Journal of Agricultural and Food Chemistry;2020-08-11

3. Novel Hybrid Compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutanamide with Antimetastatic and Cytotoxic Action: Synthesis and Anticancer Screening;Anti-Cancer Agents in Medicinal Chemistry;2019-01-23

4. Hydroxamates;Privileged Structures in Drug Discovery;2018-03-09

5. Synthesis, spectroscopy, structures and antimicrobial activity of mixed-ligand zinc(ii) complexes of 5-nitro-salicylaldehyde thiosemicarbazones;New Journal of Chemistry;2016